G Medical Innovations Holdings Ltd. to Participate at the Benzinga Healthcare Small Cap Conference

Tel Aviv and Illinois--(Newsfile Corp. - September 27, 2021) - G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) ("G Medical" or the "Company"), a telehealth, medical device, and remote patient monitoring company providing clinical-grade solutions for consumers, medical professionals, and healthcare institutions, today announced that the Company's President and Chief Executive Officer, Dr. Yacov Geva, will be presenting at the online Benzinga Healthcare Small Cap Conference at 10:30 am EDT on Thursday, September 30, 2021. The Benzinga Healthcare Small Cap Conference will be taking place from September 29-30, 2021.

Investors interested in joining the G Medical presentation can register for a free spectator pass at the link below:

https://www.benzinga.com/events/small-cap/healthcare/

About G Medical Innovations Holdings Ltd.

G Medical Innovations Holdings Ltd. is an early commercial stage healthcare company engaged in the development of next generation mHealth and telehealth solutions and monitoring service platforms. The Company's solutions and services can empower consumers, patients and providers to better monitor, manage and improve clinical and personal health outcomes, especially for those who suffer from cardiovascular disease, pulmonary disease and diabetes. The Company's current product lines consist of its Prizma medical device, a clinical grade device that can transform almost any smartphone into a medical monitoring device enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators; its Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously, including its QT Syndrome Prolongation Detection Capabilities Patch. In addition, the Company is developing its Wireless Vital Signs Monitoring System, which is expected to provide full, continuous and real time monitoring of a wide range of vital signs and biometrics. Its monitoring services include Independent Diagnostic Testing Facility and private monitoring services. For more information, please visit https://gmedinnovations.com/.

About the Benzinga Healthcare Small Cap Conference

The Benzinga Healthcare Small Cap Conference bridges the gap between Small Cap companies, investors, and traders. Learn about small cap investing with clearly defined Educational Modules, take a look at a curated group of Small Cap investment opportunities, and connect with the healthcare Small Cap audience in an intimate, virtual setting.

For more information and/or to register for the conference please visit: https://www.benzinga.com/events/small-cap/healthcare/

Forward-Looking Statements

This press release, the management presentation discussed herein, and statements of the Company's management made in connection therewith contain forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates" and similar expressions or variations of such words are intended to identify forward-looking statements. Because such statements deal with future events and are based on G Medical's current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements of G Medical could differ materially from those described in or implied by the statements in this press release. For example, G Medical is using forward-looking statements when it discusses presenting at the online Benzinga Healthcare Small Cap Conference. The forward-looking statements contained or implied in this press release, the management presentation discussed herein, and statements of the Company's management made in connection therewith are subject to other risks and uncertainties, including those discussed under the heading "Risk Factors" in G Medical's final prospectus filed pursuant to Rule 424(b)(4) dated June 24, filed with the Securities and Exchange Commission ("SEC"), and in any subsequent filings with the SEC. Except as otherwise required by law, G Medical undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. G Medical is not responsible for the contents of third-party websites.

G Medical Innovations Holdings Ltd. Company Contact

Investor Relations
TraDigital IR
Kevin McGrath
+1-646-418-7002
[email protected]

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/97696